JW (Cayman) Therapeutics Co. Ltd
JWCTF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $744,304 | $489,735 | $669,238 | $781,190 |
| - Cash | $646,880 | $757,375 | $869,034 | $1,005,909 |
| + Debt | $372,460 | $422,404 | $380,534 | $318,795 |
| Enterprise Value | $469,884 | $154,764 | $180,738 | $94,076 |
| Revenue | $106,346 | $71,403 | $86,815 | $86,116 |
| % Growth | 48.9% | -17.8% | 0.8% | – |
| Gross Profit | $65,117 | $33,571 | $43,745 | $43,406 |
| % Margin | 61.2% | 47% | 50.4% | 50.4% |
| EBITDA | -$80,067 | -$186,164 | -$204,921 | -$225,477 |
| % Margin | -75.3% | -260.7% | -236% | -261.8% |
| Net Income | -$267,265 | -$350,357 | -$240,267 | -$387,581 |
| % Margin | -251.3% | -490.7% | -276.8% | -450.1% |
| EPS Diluted | -0.64 | -0.84 | -0.58 | -0.94 |
| % Growth | 23.8% | -44.8% | 38.3% | – |
| Operating Cash Flow | $0 | -$145,239 | -$188,204 | -$160,387 |
| Capital Expenditures | $0 | -$2,353 | -$2,869 | -$5,648 |
| Free Cash Flow | $0 | -$147,592 | -$191,073 | -$166,035 |